ACOG's Green Journal highlights Columbia research in gynecologic oncology

A study authored by a team of physicians in the Department of Obstetrics and Gynecology at NewYork-Presbyterian/Columbia University Irving Medical Center was recently featured in the American College of Obstetricians and Gynecologists’ prestigious journal Obstetrics and Gynecology, also known as "The Green Journal."

Chemotherapy, Radiation, or Combination Therapy for Stage III Uterine Cancer, published in Obstetrics and Gynecology
Chemotherapy, Radiation, or Combination Therapy for Stage III Uterine Cancer, lead author Sbaa Syeda, MD, published in Obstetrics and Gynecology

The research was led by Sbaa Syeda, MD, a PGY-3 resident in the Department of Ob/Gyn. Other Columbia University faculty members including June Y. Hou, MD; Ana I. Tergas, MD, MPH; Fady Khoury-Collado, MD; Alexander Melamed, MD, MPH; Caryn St. Clair, MD; and Jason D. Wright, MD. Researchers from Columbia's Mailman School of Public Health, the Herbert Irving Comprehensive Cancer Center, Massachusetts General Hospital, and Rutgers Robert Wood Johnson Medical School and the Environmental and Occupational Health Sciences Institute (EOHSI), also contributed to the study.

The study, titled “Chemotherapy, Radiation, or Combination Therapy for Stage III Uterine Cancer,” compares the outcomes of women with stage III uterine cancer treated with chemotherapy alone, external beam radiation alone, and a combination of chemotherapy and radiation.

The research found that among women with stage III uterine cancer, combination chemotherapy and external beam radiation is associated with decreased mortality, compared with chemotherapy or radiation alone.

Read the full study here.